lactogluconic acid has been researched along with levodopa in 1 studies
Studies (lactogluconic acid) | Trials (lactogluconic acid) | Recent Studies (post-2010) (lactogluconic acid) | Studies (levodopa) | Trials (levodopa) | Recent Studies (post-2010) (levodopa) |
---|---|---|---|---|---|
11 | 2 | 4 | 17,774 | 1,900 | 4,946 |
Protein | Taxonomy | lactogluconic acid (IC50) | levodopa (IC50) |
---|---|---|---|
integrase, partial | Human immunodeficiency virus 1 | 0.5939 | |
lens epithelium-derived growth factor p75 | Homo sapiens (human) | 0.5939 | |
Epidermal growth factor receptor | Homo sapiens (human) | 2.88 | |
Tyrosine-protein kinase Lck | Homo sapiens (human) | 3.729 | |
Tyrosine-protein kinase Fyn | Homo sapiens (human) | 2.146 | |
Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 2.258 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Artigas, CF; Espino Ibáñez, A; Masmiquel Comas, L; Nicolau Ramis, J; Rivera Irigoín, R | 1 |
1 other study(ies) available for lactogluconic acid and levodopa
Article | Year |
---|---|
[Extrapyramidal symptoms due to calcinosis cerebri in a patient with unknown primary hypoparathyroidism].
Topics: Basal Ganglia Diseases; Brain Diseases, Metabolic; Calcinosis; Calcitriol; Calcium; Cognition Disorders; Depressive Disorder; Diagnosis, Differential; Dyslipidemias; Female; Gait Disorders, Neurologic; Gluconates; Humans; Hypoparathyroidism; Levodopa; Magnesium; Middle Aged; Syndrome | 2012 |